drugset / Trial / NCT05214014
Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells
Phase 1/2
Unknown
30 enrolled
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Belarusian State Medical University · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Treatment of patients with systemic sclerosis with autologous regulatory Т-cells
Timeline
- Start
- 2022-09-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Regulatory Т-cells | Cell therapy | — | — |